Remarkably, there is evidence that GLP-1 agonists can enhance left ventricular ejection fraction, inotropy, coronary blood flow, cardiac output, and vascular endothelial function because of their cardiovascular effects and decrease overall cardiovascular event risks
Additionally, recent studies indicate that GLP-1 RA can benefit individuals living with type 1 and 2 diabetes [61]
She answered that, in her first competition in nearly four years, by winning
Although retatrutide is not yet available outside of clinical trials, the factors that influence starting dose and titration speed are broadly consistent with those applied to similar licensed medicines
For women, this matters even more